Weissman James B
Chief Operating Officer & EVP at Dicerna Pharmaceuticals Inc
- Sold, on record
- $5.7M
- Dollars the filings state
- Form 4 sales
- 26
- Latest Jul 6, 2021
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- Dicerna Pharmaceuticals IncChief Operating Officer & EVP
Sales by reason
0
Routine
15
Plan not stated
0
No plan
11
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Jul 6, 2021Unusual
Sold 65.2% of their holdings
$1.2M30,000 shares at $39.09
- Apr 16, 2021Plan not stated
Sold 23.5% of their holdings
$147k4,904 shares at $29.99
- Feb 5, 2021Unusual
Sold 25.5% of their holdings
$193k7,156 shares at $26.99
- Jan 12, 2021Plan not stated
Sold 17.1% of their holdings
$140k5,808 shares at $24.08
- Jan 11, 2021Plan not stated
Sold 10.1% of their holdings
$91k3,800 shares at $23.99
- Dec 1, 2020Plan not stated
Sold 12% of their holdings
$110k4,360 shares at $25.21
- Nov 2, 2020Plan not stated
Sold 12% of their holdings
$91k4,360 shares at $20.95
- Oct 15, 2020Unusual
Sold 28.5% of their holdings
$176k8,720 shares at $20.20
- Aug 3, 2020Plan not stated
Sold 16.6% of their holdings
$98k4,360 shares at $22.47
- Jul 1, 2020Plan not stated
Sold 16.6% of their holdings
$116k4,360 shares at $26.53
10 of 26
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2024 | Jul 26, 2024 | Telesis Bio Inc. | Director | AwardedStock Option (right to buy) | 5,268 | 5,268 | SEC | ||
| Jul 24, 2024 | Jul 26, 2024 | Telesis Bio Inc. | Director | Awarded | 8,390 | 8,390 | SEC | ||
| Dec 28, 2021 | Dec 29, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Tendered | 18,100 | $38.25 | $692k | 0 | SEC |
| Dec 28, 2021 | Dec 29, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Returned to the companyRestricted Stock Units | 744,353 | 0 | SEC | ||
| Dec 15, 2021 | Dec 17, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledRestricted Stock Units | 3,775 | 11,325 | SEC | ||
| Dec 15, 2021 | Dec 17, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 3,775 | 19,775 | SEC | ||
| Dec 15, 2021 | Dec 17, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Withheld for tax | 1,675 | $38.05 | $64k | 18,100 | SEC |
| Jul 6, 2021 | Jul 8, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 30,000 | $39.09 | $1.2M | 16,000 | SEC |
| Jul 6, 2021 | Jul 8, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 30,000 | 33,999 | SEC | ||
| Jul 6, 2021 | Jul 8, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 30,000 | $9.09 | $273k | 46,000 | SEC |
| Apr 16, 2021 | Apr 20, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 4,904 | $29.99 | $147k | 16,000 | SEC |
| Feb 5, 2021 | Feb 8, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 7,156 | $26.99 | $193k | 20,904 | SEC |
| Jan 12, 2021 | Jan 13, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 5,808 | $24.08 | $140k | 28,060 | SEC |
| Jan 12, 2021 | Jan 12, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | AwardedRestricted Stock Units | 83,200 | 68,100 | SEC | ||
| Jan 11, 2021 | Jan 12, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 3,800 | $23.99 | $91k | 33,868 | SEC |
| Jan 8, 2021 | Jan 12, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledRestricted Stock Units | 8,650 | 25,950 | SEC | ||
| Jan 8, 2021 | Jan 12, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 8,650 | 40,510 | SEC | ||
| Jan 8, 2021 | Jan 12, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Withheld for tax | 2,842 | $23.29 | $66k | 37,668 | SEC |
| Dec 1, 2020 | Dec 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 4,360 | $25.21 | $110k | 31,860 | SEC |
| Dec 1, 2020 | Dec 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 0 | SEC | ||
| Dec 1, 2020 | Dec 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 4,360 | $3.42 | $15k | 36,220 | SEC |
| Nov 2, 2020 | Nov 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 4,360 | $20.95 | $91k | 31,860 | SEC |
| Nov 2, 2020 | Nov 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 4,360 | SEC | ||
| Nov 2, 2020 | Nov 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 4,360 | $3.42 | $15k | 36,220 | SEC |
| Oct 20, 2020 | Oct 22, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 10,000 | 11,879 | SEC | ||
| Oct 20, 2020 | Oct 22, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 10,000 | $2.97 | $30k | 31,860 | SEC |
| Oct 15, 2020 | Oct 19, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 8,720 | $20.20 | $176k | 21,860 | SEC |
| Oct 15, 2020 | Oct 19, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 8,720 | 8,720 | SEC | ||
| Oct 15, 2020 | Oct 19, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 8,720 | $3.42 | $30k | 30,580 | SEC |
| Aug 3, 2020 | Aug 5, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Sold | 4,360 | $22.47 | $98k | 21,860 | SEC |
| Aug 3, 2020 | Aug 5, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 17,440 | SEC | ||
| Aug 3, 2020 | Aug 5, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Exercised options | 4,360 | $3.00 | $13k | 26,220 | SEC |
| Jul 1, 2020 | Jul 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 4,360 | $26.53 | $116k | 21,860 | SEC |
| Jul 1, 2020 | Jul 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 25,980 | SEC | ||
| Jul 1, 2020 | Jul 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 4,360 | $2.97 | $13k | 26,220 | SEC |
| Jun 1, 2020 | Jun 2, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 4,360 | $21.06 | $92k | 21,860 | SEC |
| Jun 1, 2020 | Jun 2, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 30,340 | SEC | ||
| Jun 1, 2020 | Jun 2, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 4,360 | $2.97 | $13k | 26,220 | SEC |
| May 4, 2020 | May 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 4,360 | $20.20 | $88k | 21,860 | SEC |
| May 4, 2020 | May 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 34,700 | SEC | ||
| May 4, 2020 | May 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 4,360 | $2.97 | $13k | 26,220 | SEC |
| Apr 13, 2020 | Apr 14, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Sold | 4,360 | $20.20 | $88k | 21,860 | SEC |
| Apr 13, 2020 | Apr 14, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 39,060 | SEC | ||
| Apr 13, 2020 | Apr 14, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Exercised options | 4,360 | $2.97 | $13k | 26,220 | SEC |
| Mar 2, 2020 | Mar 3, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Sold | 4,360 | $20.61 | $90k | 21,860 | SEC |
| Mar 2, 2020 | Mar 3, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 43,420 | SEC | ||
| Mar 2, 2020 | Mar 3, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Exercised options | 4,360 | $2.97 | $13k | 26,220 | SEC |
| Feb 3, 2020 | Feb 4, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Sold | 4,360 | $20.20 | $88k | 21,860 | SEC |
| Feb 3, 2020 | Feb 4, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Exercised or settledEmployee Stock Option (Right to Buy) | 4,360 | 47,780 | SEC | ||
| Feb 3, 2020 | Feb 4, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Exercised options | 4,360 | $2.97 | $13k | 26,220 | SEC |
Page 1
Sales and notices (26)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 | Jul 8, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 30,000 | $1.2M | 65.2% | Unusual | SEC |
| Apr 16, 2021 | Apr 20, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 4,904 | $147k | 23.5% | Plan not stated | SEC |
| Feb 5, 2021 | Feb 8, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 7,156 | $193k | 25.5% | Unusual | SEC |
| Jan 12, 2021 | Jan 13, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 5,808 | $140k | 17.1% | Plan not stated | SEC |
| Jan 11, 2021 | Jan 12, 2021 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 3,800 | $91k | 10.1% | Plan not stated | SEC |
| Dec 1, 2020 | Dec 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 4,360 | $110k | 12.0% | Plan not stated | SEC |
| Nov 2, 2020 | Nov 3, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 4,360 | $91k | 12.0% | Plan not stated | SEC |
| Oct 15, 2020 | Oct 19, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 8,720 | $176k | 28.5% | Unusual | SEC |
| Aug 3, 2020 | Aug 5, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 4,360 | $98k | 16.6% | Plan not stated | SEC |
| Jul 1, 2020 | Jul 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 4,360 | $116k | 16.6% | Plan not stated | SEC |
| Jun 1, 2020 | Jun 2, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 4,360 | $92k | 16.6% | Plan not stated | SEC |
| May 4, 2020 | May 6, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 4,360 | $88k | 16.6% | Plan not stated | SEC |
| Apr 13, 2020 | Apr 14, 2020 | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | Form 4 sale | 4,360 | $88k | 16.6% | Plan not stated | SEC |
| Mar 2, 2020 | Mar 3, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 4,360 | $90k | 16.6% | Plan not stated | SEC |
| Feb 3, 2020 | Feb 4, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 4,360 | $88k | 16.6% | Plan not stated | SEC |
| Jan 2, 2020 | Jan 3, 2020 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 4,360 | $95k | 16.6% | Plan not stated | SEC |
| Dec 2, 2019 | Dec 3, 2019 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 20,000 | $520k | 57.6% | Unusual | SEC |
| Nov 19, 2019 | Nov 20, 2019 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 40,000 | $920k | 73.1% | Unusual | SEC |
| Nov 14, 2019 | Nov 15, 2019 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 20,000 | $400k | 57.6% | Unusual | SEC |
| Oct 31, 2019 | Nov 1, 2019 | Dicerna Pharmaceuticals Inc | EVP & Chief Operating Officer | Form 4 sale | 15,000 | $270k | 50.5% | Unusual | SEC |
| Aug 23, 2019 | Aug 23, 2019 | Dicerna Pharmaceuticals Inc | Chief Business Officer | Form 4 sale | 14,680 | $192k | 60.0% | Unusual | SEC |
| Apr 2, 2019 | Apr 4, 2019 | Dicerna Pharmaceuticals Inc | Chief Business Officer | Form 4 sale | 15,000 | $225k | 38.0% | Unusual | SEC |
| Sep 5, 2018 | Sep 6, 2018 | Dicerna Pharmaceuticals Inc | Chief Business Officer | Form 4 sale | 2,301 | $40k | 8.6% | Plan not stated | SEC |
| May 9, 2018 | May 11, 2018 | Dicerna Pharmaceuticals Inc | Chief Business Officer | Form 4 sale | 10,000 | $150k | 50.5% | Unusual | SEC |
| Apr 20, 2018 | Apr 24, 2018 | Dicerna Pharmaceuticals Inc | Chief Business Officer | Form 4 sale | 8,965 | $117k | 47.8% | Unusual | SEC |
| Mar 19, 2018 | Mar 21, 2018 | Dicerna Pharmaceuticals Inc | Chief Business Officer | Form 4 sale | 1,035 | $13k | 5.2% | Plan not stated | SEC |